LAT and small cell lung carcinoma: The LAT inhibitor reduced the uptake of both radiotracers by 97% at 37 °C, suggesting that LAT is the predominant uptake mechanism for [18F]2-FPTRP and [18F]5-FPTRP in small cell lung cancer cells.